Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tisotumab vedotin
tisotumab vedotin
Seattle Genetics/Genmab's tisotumab’s cervical cancer efficacy falls off
EP Vantage
Tue, 06/30/20 - 10:34 am
cervical cancer
tisotumab vedotin
Genmab
Seattle Genetics
clinical trials
Upcoming events – Genmab's route to market, and late-stage data for Zogenix
EP Vantage
Fri, 01/24/20 - 10:50 am
Genmab
tisotumab vedotin
cervical cancer
Zogenix
Fintepla
Lennox-Gastaut Syndrome
Seattle Genetics Doses First Patient In Ph II Trial of Antibody-drug Conjugate in Multiple Solid Tumors
CP Wire
Thu, 07/12/18 - 09:17 am
Seattle Genetics
colorectal cancer
non-small cell lung cancer
pancreatic cancer
head and neck cancer
cervical cancer
tisotumab vedotin
Genmab
clinical trials
Seven years in the making, Seattle Genetics picks up early option on Genmab’s ADC effort
Endpoints
Tue, 08/29/17 - 09:36 am
Seattle Genetics
Genmab
antibody-drug conjugate
tisotumab vedotin